Riskpilot← Back to searchSign inGet full accessNöbbelövs Läkarkonsult AB
ABIn liquidationOrg 5569466682Hospital activities · NACE 8610Est. 20130 employees
Revenue 2020
SEK 0
EBITDA margin
—
-28% vs 2019
Equity ratio
86.5%
Financial strength
Net profit 2020
SEK 86K
-52% vs 2019
| Revenue | SEK 0 | — |
| EBITDA | SEK -23K | -28% |
| Net profit | SEK 86K | -52% |
| Total assets | SEK 163K | -55% |
| Equity | SEK 141K | -40% |
| Employees | 0 | — |
Legal name
Nöbbelövs Läkarkonsult AB
Org number
5569466682
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
28 oktober 2013
Share capital
SEK 0
Employees
0
VAT registered
No
Audit selected
No
Last report
2020-12-31
Financial year
January – December
Company purpose
Aktiebolaget ska erbjuda kvalificerad kunskap inom ortopedi och bedriva förvaltning av värdepapper jämte därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| Revenue | 648 | 345 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 560 | 296 | −12 | −18 | −23 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 560 | 296 | −12 | −18 | −23 |
| Net financials | — | — | — | — | 18 |
| Profit before tax | 420 | 226 | 89 | 227 | 106 |
| Tax | −93 | −50 | −20 | −49 | −20 |
| Net profit | 327 | 176 | 69 | 178 | 86 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| Total assets | 923 | 834 | 634 | 359 | 163 |
| Equity | 487 | 363 | 232 | 235 | 141 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 50 | 16 | 47 | 14 | 22 |
| Total debt | 50 | 16 | 47 | 14 | 22 |
EBITDA margin
-2300000.0%
This company
15.8%
Market median
-14557062% vs market
20162020
Equity ratio
86.5%
This company
38.2%
Market median
+126% vs market
20162020
Return on equity
61.0%
This company
18.4%
Market median
+232% vs market
20162020
Net profit margin
8600000.0%
This company
8.1%
Market median
+106172740% vs market
20162020
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20162020
Debt / equity
0.16×
This company
0.62×
Market median
+74% vs market
20162020
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
LG External Signatory | External Signatory | 2021 |
IM External Signatory | External Signatory | 2021 |
BJ Liquidator | Liquidator | 2021 |
UM External Signatory | External Signatory | 2021 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Deputy Board Member | 2021 – 2021 | |
| Board of Directors | 2021 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Nöbbelövs Läkarkonsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Leif Gustav Andersson | External Signatory | 0 companies |
| Inger Margareta Dahle | External Signatory | 0 companies |
| Bengt Junior Niklas Nygårds | Liquidator | 0 companies |
| Ulrika Margareta Ahlholm | External Signatory | 0 companies |
| Nils Gunnar Nilsson | Deputy Board Member | 0 companies |
| Lars Ture Nilsson | Board of Directors | 0 companies |